Alberta Health and Wellness Minister Ron Liepert announced details of the first phase of the province's major new pharmaceutical strategy on December 8.
Pharmacists in London, England will receive authorization next year to supply women with the oral contraceptive pill over-the-counter-without the need for a doctor's prescription-as part of a new pilot project.
GlaxoSmithKline's Volibris is a new endothelin receptor antagonist for the treatment of idiopathic (primary) pulmonary arterial hypertension, as well as PAH associated with connective tissue disease.
